Skip to main content
icon for Will CVS Health (CVS) beat quarterly earnings?
Pendapatan·Ekuitas

Will CVS Health (CVS) beat quarterly earnings?

icon for Will CVS Health (CVS) beat quarterly earnings?
Pendapatan·Ekuitas

Will CVS Health (CVS) beat quarterly earnings?

Aug 5

Aug 5

61% peluang
Polymarket
BARU
61% peluang
Polymarket
BARU
As of market creation, CVS Health is estimated to release earnings on August 5, 2026. The Street consensus estimate for CVS Health’s non-GAAP EPS for the relevant quarter is $1.84 as of market creation. This market will resolve to "Yes" if CVS Health reports non-GAAP EPS greater than $1.84 for the relevant quarter in its next quarterly earnings release. Otherwise, it will resolve to "No." The resolution source will be the non-GAAP EPS listed in the company’s official earnings documents. If CVS Health releases earnings without non-GAAP EPS, then the market will resolve according to the non-GAAP EPS figure reported by SeekingAlpha. If no such figure is published within 96h of market close (4:00:00pm ET) on the day earnings are announced, the market will resolve according to the GAAP EPS listed in the company’s official earnings documents; or, if not published there, according to the GAAP EPS provided by SeekingAlpha. If no GAAP EPS number is available from either source at that time, the market will resolve to “No.” (For the purposes of this market, GAAP EPS refers to diluted GAAP EPS, unless it is not published, in which case it refers to basic GAAP EPS.) If the company does not release earnings within 45 calendar days of the estimated earnings date, this market will resolve to “No.” Note: Subsequent restatements, corrections, or revisions made to the initially announced non-GAAP EPS figure will not qualify for resolution, except in the case of obvious and immediate mistakes (e.g., fat finger errors, as with Lyft's (LYFT) earnings release in February 2024). Note: The strike prices used in these markets are derived from SeekingAlpha estimates, and reflect the consensus of sell-side analyst estimates for non-GAAP EPS. Note: All figures will be rounded to the nearest cent using standard rounding. Note: For the purposes of this market, IFRS EPS will be treated as GAAP EPS. Note: If multiple versions of non-GAAP EPS are published, the market will resolve according to the primary headline non-GAAP EPS number, which is typically presented on a diluted basis. If diluted is not published, then basic non-GAAP EPS will qualify. Note: All figures are expressed in USD, unless otherwise indicated. Note: For primarily internationally listed companies, this market refers specifically to the shares traded in the United States on U.S. stock exchanges such as the NYSE or Nasdaq. In cases where the company trades in the U.S. through an American Depositary Receipt (ADR) or American Depositary Share (ADS), this market will refer to the ADR/ADS. CVS Health's recent momentum from its Q1 2026 earnings beat and raised full-year guidance underpins the 61% market-implied probability of another quarterly beat. Adjusted EPS of $2.57 exceeded consensus by $0.36, with revenues rising 6.2% year-over-year to $100.4 billion, prompting upward revisions to 2026 adjusted EPS guidance to $7.30–$7.50. Share price strength near $108 reflects this trajectory, alongside multiple analyst price target increases. Traders weigh these positive fundamentals against ongoing cost pressures and macro uncertainty, creating a modest edge for outperformance ahead of the Q2 release expected in late July.

As of market creation, CVS Health is estimated to release earnings on August 5, 2026. The Street consensus estimate for CVS Health’s non-GAAP EPS for the relevant quarter is $1.84 as of market creation. This market will resolve to "Yes" if CVS Health reports non-GAAP EPS greater than $1.84 for the relevant quarter in its next quarterly earnings release. Otherwise, it will resolve to "No." The resolution source will be the non-GAAP EPS listed in the company’s official earnings documents.

If CVS Health releases earnings without non-GAAP EPS, then the market will resolve according to the non-GAAP EPS figure reported by SeekingAlpha. If no such figure is published within 96h of market close (4:00:00pm ET) on the day earnings are announced, the market will resolve according to the GAAP EPS listed in the company’s official earnings documents; or, if not published there, according to the GAAP EPS provided by SeekingAlpha. If no GAAP EPS number is available from either source at that time, the market will resolve to “No.” (For the purposes of this market, GAAP EPS refers to diluted GAAP EPS, unless it is not published, in which case it refers to basic GAAP EPS.)

If the company does not release earnings within 45 calendar days of the estimated earnings date, this market will resolve to “No.”

Note: Subsequent restatements, corrections, or revisions made to the initially announced non-GAAP EPS figure will not qualify for resolution, except in the case of obvious and immediate mistakes (e.g., fat finger errors, as with Lyft's (LYFT) earnings release in February 2024).
Note: The strike prices used in these markets are derived from SeekingAlpha estimates, and reflect the consensus of sell-side analyst estimates for non-GAAP EPS.
Note: All figures will be rounded to the nearest cent using standard rounding.
Note: For the purposes of this market, IFRS EPS will be treated as GAAP EPS.
Note: If multiple versions of non-GAAP EPS are published, the market will resolve according to the primary headline non-GAAP EPS number, which is typically presented on a diluted basis. If diluted is not published, then basic non-GAAP EPS will qualify.
Note: All figures are expressed in USD, unless otherwise indicated.
Note: For primarily internationally listed companies, this market refers specifically to the shares traded in the United States on U.S. stock exchanges such as the NYSE or Nasdaq. In cases where the company trades in the U.S. through an American Depositary Receipt (ADR) or American Depositary Share (ADS), this market will refer to the ADR/ADS.
Volume
$0
Tanggal Berakhir
Aug 5, 2026
Pasar Dibuka
Jul 23, 2026, 10:32 PM ET

Sumber Resolusi

https://seekingalpha.com/

Resolver

0x65070BE91...
As of market creation, CVS Health is estimated to release earnings on August 5, 2026. The Street consensus estimate for CVS Health’s non-GAAP EPS for the relevant quarter is $1.84 as of market creation. This market will resolve to "Yes" if CVS Health reports non-GAAP EPS greater than $1.84 for the relevant quarter in its next quarterly earnings release. Otherwise, it will resolve to "No." The resolution source will be the non-GAAP EPS listed in the company’s official earnings documents. If CVS Health releases earnings without non-GAAP EPS, then the market will resolve according to the non-GAAP EPS figure reported by SeekingAlpha. If no such figure is published within 96h of market close (4:00:00pm ET) on the day earnings are announced, the market will resolve according to the GAAP EPS listed in the company’s official earnings documents; or, if not published there, according to the GAAP EPS provided by SeekingAlpha. If no GAAP EPS number is available from either source at that time, the market will resolve to “No.” (For the purposes of this market, GAAP EPS refers to diluted GAAP EPS, unless it is not published, in which case it refers to basic GAAP EPS.) If the company does not release earnings within 45 calendar days of the estimated earnings date, this market will resolve to “No.” Note: Subsequent restatements, corrections, or revisions made to the initially announced non-GAAP EPS figure will not qualify for resolution, except in the case of obvious and immediate mistakes (e.g., fat finger errors, as with Lyft's (LYFT) earnings release in February 2024). Note: The strike prices used in these markets are derived from SeekingAlpha estimates, and reflect the consensus of sell-side analyst estimates for non-GAAP EPS. Note: All figures will be rounded to the nearest cent using standard rounding. Note: For the purposes of this market, IFRS EPS will be treated as GAAP EPS. Note: If multiple versions of non-GAAP EPS are published, the market will resolve according to the primary headline non-GAAP EPS number, which is typically presented on a diluted basis. If diluted is not published, then basic non-GAAP EPS will qualify. Note: All figures are expressed in USD, unless otherwise indicated. Note: For primarily internationally listed companies, this market refers specifically to the shares traded in the United States on U.S. stock exchanges such as the NYSE or Nasdaq. In cases where the company trades in the U.S. through an American Depositary Receipt (ADR) or American Depositary Share (ADS), this market will refer to the ADR/ADS.
As of market creation, CVS Health is estimated to release earnings on August 5, 2026. The Street consensus estimate for CVS Health’s non-GAAP EPS for the relevant quarter is $1.84 as of market creation. This market will resolve to "Yes" if CVS Health reports non-GAAP EPS greater than $1.84 for the relevant quarter in its next quarterly earnings release. Otherwise, it will resolve to "No." The resolution source will be the non-GAAP EPS listed in the company’s official earnings documents. If CVS Health releases earnings without non-GAAP EPS, then the market will resolve according to the non-GAAP EPS figure reported by SeekingAlpha. If no such figure is published within 96h of market close (4:00:00pm ET) on the day earnings are announced, the market will resolve according to the GAAP EPS listed in the company’s official earnings documents; or, if not published there, according to the GAAP EPS provided by SeekingAlpha. If no GAAP EPS number is available from either source at that time, the market will resolve to “No.” (For the purposes of this market, GAAP EPS refers to diluted GAAP EPS, unless it is not published, in which case it refers to basic GAAP EPS.) If the company does not release earnings within 45 calendar days of the estimated earnings date, this market will resolve to “No.” Note: Subsequent restatements, corrections, or revisions made to the initially announced non-GAAP EPS figure will not qualify for resolution, except in the case of obvious and immediate mistakes (e.g., fat finger errors, as with Lyft's (LYFT) earnings release in February 2024). Note: The strike prices used in these markets are derived from SeekingAlpha estimates, and reflect the consensus of sell-side analyst estimates for non-GAAP EPS. Note: All figures will be rounded to the nearest cent using standard rounding. Note: For the purposes of this market, IFRS EPS will be treated as GAAP EPS. Note: If multiple versions of non-GAAP EPS are published, the market will resolve according to the primary headline non-GAAP EPS number, which is typically presented on a diluted basis. If diluted is not published, then basic non-GAAP EPS will qualify. Note: All figures are expressed in USD, unless otherwise indicated. Note: For primarily internationally listed companies, this market refers specifically to the shares traded in the United States on U.S. stock exchanges such as the NYSE or Nasdaq. In cases where the company trades in the U.S. through an American Depositary Receipt (ADR) or American Depositary Share (ADS), this market will refer to the ADR/ADS. CVS Health's recent momentum from its Q1 2026 earnings beat and raised full-year guidance underpins the 61% market-implied probability of another quarterly beat. Adjusted EPS of $2.57 exceeded consensus by $0.36, with revenues rising 6.2% year-over-year to $100.4 billion, prompting upward revisions to 2026 adjusted EPS guidance to $7.30–$7.50. Share price strength near $108 reflects this trajectory, alongside multiple analyst price target increases. Traders weigh these positive fundamentals against ongoing cost pressures and macro uncertainty, creating a modest edge for outperformance ahead of the Q2 release expected in late July.

As of market creation, CVS Health is estimated to release earnings on August 5, 2026. The Street consensus estimate for CVS Health’s non-GAAP EPS for the relevant quarter is $1.84 as of market creation. This market will resolve to "Yes" if CVS Health reports non-GAAP EPS greater than $1.84 for the relevant quarter in its next quarterly earnings release. Otherwise, it will resolve to "No." The resolution source will be the non-GAAP EPS listed in the company’s official earnings documents.

If CVS Health releases earnings without non-GAAP EPS, then the market will resolve according to the non-GAAP EPS figure reported by SeekingAlpha. If no such figure is published within 96h of market close (4:00:00pm ET) on the day earnings are announced, the market will resolve according to the GAAP EPS listed in the company’s official earnings documents; or, if not published there, according to the GAAP EPS provided by SeekingAlpha. If no GAAP EPS number is available from either source at that time, the market will resolve to “No.” (For the purposes of this market, GAAP EPS refers to diluted GAAP EPS, unless it is not published, in which case it refers to basic GAAP EPS.)

If the company does not release earnings within 45 calendar days of the estimated earnings date, this market will resolve to “No.”

Note: Subsequent restatements, corrections, or revisions made to the initially announced non-GAAP EPS figure will not qualify for resolution, except in the case of obvious and immediate mistakes (e.g., fat finger errors, as with Lyft's (LYFT) earnings release in February 2024).
Note: The strike prices used in these markets are derived from SeekingAlpha estimates, and reflect the consensus of sell-side analyst estimates for non-GAAP EPS.
Note: All figures will be rounded to the nearest cent using standard rounding.
Note: For the purposes of this market, IFRS EPS will be treated as GAAP EPS.
Note: If multiple versions of non-GAAP EPS are published, the market will resolve according to the primary headline non-GAAP EPS number, which is typically presented on a diluted basis. If diluted is not published, then basic non-GAAP EPS will qualify.
Note: All figures are expressed in USD, unless otherwise indicated.
Note: For primarily internationally listed companies, this market refers specifically to the shares traded in the United States on U.S. stock exchanges such as the NYSE or Nasdaq. In cases where the company trades in the U.S. through an American Depositary Receipt (ADR) or American Depositary Share (ADS), this market will refer to the ADR/ADS.
Volume
$0
Tanggal Berakhir
Aug 5, 2026
Pasar Dibuka
Jul 23, 2026, 10:32 PM ET

Sumber Resolusi

https://seekingalpha.com/

Resolver

0x65070BE91...
As of market creation, CVS Health is estimated to release earnings on August 5, 2026. The Street consensus estimate for CVS Health’s non-GAAP EPS for the relevant quarter is $1.84 as of market creation. This market will resolve to "Yes" if CVS Health reports non-GAAP EPS greater than $1.84 for the relevant quarter in its next quarterly earnings release. Otherwise, it will resolve to "No." The resolution source will be the non-GAAP EPS listed in the company’s official earnings documents. If CVS Health releases earnings without non-GAAP EPS, then the market will resolve according to the non-GAAP EPS figure reported by SeekingAlpha. If no such figure is published within 96h of market close (4:00:00pm ET) on the day earnings are announced, the market will resolve according to the GAAP EPS listed in the company’s official earnings documents; or, if not published there, according to the GAAP EPS provided by SeekingAlpha. If no GAAP EPS number is available from either source at that time, the market will resolve to “No.” (For the purposes of this market, GAAP EPS refers to diluted GAAP EPS, unless it is not published, in which case it refers to basic GAAP EPS.) If the company does not release earnings within 45 calendar days of the estimated earnings date, this market will resolve to “No.” Note: Subsequent restatements, corrections, or revisions made to the initially announced non-GAAP EPS figure will not qualify for resolution, except in the case of obvious and immediate mistakes (e.g., fat finger errors, as with Lyft's (LYFT) earnings release in February 2024). Note: The strike prices used in these markets are derived from SeekingAlpha estimates, and reflect the consensus of sell-side analyst estimates for non-GAAP EPS. Note: All figures will be rounded to the nearest cent using standard rounding. Note: For the purposes of this market, IFRS EPS will be treated as GAAP EPS. Note: If multiple versions of non-GAAP EPS are published, the market will resolve according to the primary headline non-GAAP EPS number, which is typically presented on a diluted basis. If diluted is not published, then basic non-GAAP EPS will qualify. Note: All figures are expressed in USD, unless otherwise indicated. Note: For primarily internationally listed companies, this market refers specifically to the shares traded in the United States on U.S. stock exchanges such as the NYSE or Nasdaq. In cases where the company trades in the U.S. through an American Depositary Receipt (ADR) or American Depositary Share (ADS), this market will refer to the ADR/ADS.

Terkait

icon for Will MetLife (MET) beat quarterly earnings?

Will MetLife (MET) beat quarterly earnings?

56%
icon for Will Cabot (CBT) beat quarterly earnings?

Will Cabot (CBT) beat quarterly earnings?

74%
icon for Will Cigna Group (CI) beat quarterly earnings?

Will Cigna Group (CI) beat quarterly earnings?

92%

Hati-hati dengan link eksternal.

Pertanyaan yang Sering Diajukan

"Will CVS Health (CVS) beat quarterly earnings?" adalah pasar prediksi di Polymarket di mana trader membeli dan menjual saham "Ya" atau "Tidak" berdasarkan apakah mereka yakin event ini akan terjadi. Probabilitas crowd-sourced saat ini adalah 61% untuk "Yes." Misalnya, jika "Ya" dihargai 61¢, pasar secara kolektif memberikan peluang 61% bahwa event ini akan terjadi. Peluang ini bergeser terus-menerus saat trader bereaksi terhadap perkembangan dan informasi baru. Saham dengan hasil yang benar bisa ditukarkan seharga $1 setiap saham saat pasar diselesaikan.

"Will CVS Health (CVS) beat quarterly earnings?" adalah pasar yang baru dibuat di Polymarket, diluncurkan pada Jul 23, 2026. Sebagai pasar awal, ini adalah kesempatanmu untuk menjadi salah satu trader pertama yang menetapkan peluang dan membangun sinyal harga awal pasar. Kamu juga bisa menandai halaman ini untuk melacak volume dan aktivitas trading seiring pasar mendapatkan traksi.

Untuk trading di "Will CVS Health (CVS) beat quarterly earnings?," cukup pilih apakah kamu yakin jawabannya "Ya" atau "Tidak." Setiap sisi memiliki harga saat ini yang mencerminkan probabilitas tersirat pasar. Masukkan jumlah kamu dan klik "Trade." Jika kamu membeli saham "Ya" dan hasilnya diselesaikan sebagai "Ya," setiap saham membayar $1. Jika diselesaikan sebagai "Tidak," saham "Ya" kamu bernilai $0. Kamu juga bisa menjual sahammu kapan saja sebelum resolusi jika kamu ingin mengamankan keuntungan atau memotong kerugian.

Probabilitas saat ini untuk "Will CVS Health (CVS) beat quarterly earnings?" adalah 61% untuk "Yes." Ini berarti keramaian Polymarket saat ini percaya ada peluang 61% bahwa event ini akan terjadi. Peluang ini diperbarui secara real-time berdasarkan trade aktual, memberikan sinyal yang terus diperbarui tentang apa yang diharapkan pasar.

Aturan resolusi untuk "Will CVS Health (CVS) beat quarterly earnings?" mendefinisikan dengan tepat apa yang harus terjadi agar setiap hasil dinyatakan sebagai pemenang — termasuk sumber data resmi yang digunakan untuk menentukan hasilnya. Kamu bisa meninjau kriteria resolusi lengkap di bagian "Aturan" di halaman ini di atas komentar. Kami menyarankan membaca aturan dengan cermat sebelum trading, karena mereka menentukan kondisi tepat, kasus khusus, dan sumber yang mengatur bagaimana pasar ini diselesaikan.